Dr. Chibuzo C. O'suoji
M.D. | Pediatric Hematology-Oncology | Female
Dr. Chibuzo C. O'suoji, M.D. is a Lubbock, Texas based Pediatric doctor with medical specialization in
Pediatric Hematology-Oncology.
Current practice location of Dr. Chibuzo C. O'suoji is
602 Indiana Ave, Lubbock, Texas - 79415. She can be contacted on phone at
806-775-8600 and fax number 806-775-8602.
Dr. Chibuzo C. O'suoji is a sole proprietor of her business.
NPI number (Unique professional ID) for Dr. Chibuzo C. O'suoji is
1952523458 which was assigned by NPPES on 03 May, 2007 and it was last updated on 09 Dec, 2021.
Dr. Chibuzo C. O'suoji license number is
46303 for Pediatrics Pediatric Hematology-Oncology (2080P0207X) in Texas.
Dr. Chibuzo C. O'suoji is trained in the combination of pediatrics, hematology and oncology to recognize and manage pediatric blood disorders and cancerous diseases.
Complete Profile:
Dr. Chibuzo C. O'suoji basic information including her official name, gender, specialization, credentials etc. are as mentioned below.
| Specialization : | Pediatrics Pediatric Hematology-Oncology |
|---|
| Provider Name : | Dr. Chibuzo C. O'suoji |
|---|
| Credential : | M.D. |
|---|
| Gender : | Female |
|---|
Business Address:
Dr. Chibuzo C. O'suoji address, contact phone number and fax are as below. Patients can directly walkin to the clinic or can call on the below given phone number for appointment.
| Primary Address : | 602 Indiana Ave
Lubbock, TX, 79415
United States |
|---|
| Phone Number : | 806-775-8600 |
|---|
| Fax Number : | 806-775-8602 |
|---|
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
| NPI Number : | 1952523458 |
|---|
| NPI Entity Type : | Individual |
|---|
| First Enrolment Date : | 03 May, 2007 |
|---|
| Last Updated On : | 09 Dec, 2021 |
|---|
Licenses and Specialities:
Physicians/Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Chibuzo C. O'suoji are as mentioned. Primary taxonomy code for Dr. Chibuzo C. O'suoji, M.D. is
2080P0207X (Pediatrics Pediatric Hematology-Oncology).
| Taxonomy Code | Speciality | Primary | License No. | State |
|---|
| 2080P0207X | Pediatrics Pediatric Hematology-Oncology | Yes | 46303 | TX |
Legacy Identifiers:
Other legacy medical identifiers of Dr. Chibuzo C. O'suoji such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned below.
| Identifier | Identifier Type | State | Issuer |
|---|
| 3810021936 | MEDICAID | WV | |
Other Practice Locations:
| Practice Address | City, State | Phone Number |
|---|
830 PENNSYLVANIA AVE, SUITE 103
CHARLESTON, WV, 25302
United States | CHARLESTON, WV | 304-388-1552 |
830 PENNSYLVANIA AVE, SUITE 103
CHARLESTON, WV, 25302
United States | CHARLESTON, WV | 304-388-1552 |
Endpoints:
Endpoints provide a simple, secure, scalable, and standards-based way for participants to send authenticated, encrypted health information directly to known, trusted recipients over the Internet. It is used by EHR systems (Electronic Health Records).
| Endpoint Type | Endpoint | Affiliation | Use | Content | Address |
|---|
DIRECT
(Direct Messaging Address) | chibuzo.osuoji@direct.myteamcare.com
| No affiliation |
|
| 3601 4TH ST,
LUBBOCK, TX, 79430-0002
United States |
Mailing Address:
Mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned business address only.
| Mailing Address : | Po Box 5865
Lubbock, TX, 79408-5865
United States |
|---|
| Phone Number : | 806-743-2898 |
|---|
| Fax Number : | 806-743-2787 |
|---|
Business Location:
Patients can refer following map for directions to
Dr. Chibuzo C. O'suoji practice address. Don't forget to take prior appointment before visiting.
** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 January, 2024.